UNSPSC 85811002: Introduction of monoclonal antibody into peritoneal cavity, via natural or artificial opening

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of monoclonal antibody into peritoneal cavity, via natural or artificial opening. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0M70M

UNSPSC 85811002, Introduction of monoclonal antibody into peritoneal cavity via natural or artificial opening, is a Commodity code that does not align with recent state and local procurement activity. The recent opportunities tagged under this code encompass virtual urgent care services, occupational health services, medical directorships, cancer screening, wellness platforms, opioid use disorder treatment, behavioral health services, nursing home operations, medical examinations, and clinical staffing — none of which involve monoclonal antibody administration or peritoneal cavity procedures. This code appears to be a medical procedure classification used inconsistently or incorrectly by issuing bodies; state and local procurement activity under this code does not reflect its nominal clinical scope.

The mismatch suggests that either the code is being applied to misclassified opportunities or that the specific procedure this code describes does not feature prominently in current state and local healthcare procurement. If monoclonal antibody therapies are being procured by state or local health systems, they are likely tagged under different codes reflecting pharmaceutical supplies, infusion services, or specialty pharmacy management rather than this procedure-specific Commodity code. Entities evaluating this code should verify the actual clinical services or supplies their organization requires before assuming activity under 85811002 will surface relevant procurement leads.